BGLU29 Antibody

Shipped with Ice Packs
In Stock

Description

Current Antibody Research Landscape

The search results highlight active research in antibody engineering, including:

  • IgG subclasses (e.g., IgG1–IgG4) and their roles in immune responses .

  • Next-generation antibody formats such as bispecific antibodies (BsAb), antibody-drug conjugates (ADCs), and broadly neutralizing antibodies (bNAbs) targeting viruses like dengue and SARS-CoV-2 .

  • Autoimmune disease mechanisms linked to dysfunctional B cells .

None of these studies reference "BGLU29" as a recognized antibody or target.

Analysis of "BGLU" Terminology

  • BGLU enzymes are hydrolytic proteins involved in metabolic pathways, not antibodies .

  • Antibody nomenclature typically follows conventions like "Ig" (immunoglobulin) prefixes or target-specific names (e.g., anti-CD20) .

The term "BGLU29 Antibody" does not align with established naming practices for antibodies or enzymes in the literature reviewed.

Typographical Error

If "BGLU29" was intended to refer to a known antibody (e.g., BGLU15), limited data exists:

PropertyBGLU15 (β-Glucosidase 15)
OrganismArabidopsis thaliana
FunctionHydrolyzes flavonol bisglycosides
RelevancePlant secondary metabolism
Antibody StatusNo commercial or therapeutic use

Emerging or Proprietary Compound

"BGLU29" may represent an undisclosed or early-stage research target not yet published or cataloged in public databases.

Recommendations for Further Inquiry

To resolve ambiguity:

  1. Verify nomenclature with the Human Genome Organization (HUGO) or UniProt databases.

  2. Explore patent filings (e.g., USPTO, WIPO) for proprietary antibody candidates.

  3. Contact developers at institutions like Invivyd or Genentech, which focus on novel antibody therapies .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
BGLU29 antibody; At2g44470 antibody; F4I1.28Beta-glucosidase 29 antibody; AtBGLU29 antibody; EC 3.2.1.21 antibody
Target Names
BGLU29
Uniprot No.

Q&A

Experimental Design for BGLU29 Antibody Studies

Q: How should I design experiments to study the function of BGLU29 using its antibody? A: To study the function of BGLU29, you can use a combination of biochemical assays and cellular experiments. First, validate the specificity of the BGLU29 antibody using Western blot or ELISA. Then, use the antibody for immunoprecipitation to identify interacting proteins or for immunofluorescence to study its localization. Additionally, consider using RNA interference or CRISPR-Cas9 to knockdown BGLU29 and observe the effects on cellular processes.

Data Analysis and Contradiction Resolution

Q: How do I resolve contradictory data when using BGLU29 antibodies in different experimental setups? A: Contradictory data can arise from differences in antibody specificity, experimental conditions, or sample preparation. To resolve this, ensure that the same antibody batch is used across experiments. Validate the antibody's specificity using multiple methods (e.g., Western blot, ELISA). Also, consider factors like protein degradation or post-translational modifications that might affect detection.

Advanced Research Questions: Epitope Mapping

Q: What methods can I use to map the epitope recognized by the BGLU29 antibody? A: Epitope mapping can be achieved through several methods:

  • Peptide Array: Use a peptide array representing different regions of the BGLU29 protein to identify which peptides bind to the antibody.

  • Mutagenesis: Introduce point mutations into the BGLU29 protein and assess the effect on antibody binding.

  • X-ray Crystallography or Cryo-EM: Determine the structure of the antibody-BGLU29 complex to identify the epitope directly.

Methodological Considerations: Antibody Validation

Q: How do I validate the specificity of BGLU29 antibodies for research use? A: Validation involves several steps:

  • Western Blot: Confirm the antibody recognizes a band of the expected size for BGLU29.

  • ELISA: Use ELISA to quantify the antibody's binding affinity to BGLU29.

  • Immunofluorescence: Verify the antibody's ability to stain cells expressing BGLU29.

  • Knockdown/Knockout Controls: Use cells with knocked down or knocked out BGLU29 to ensure specificity.

Advanced Techniques: Nanobodies and Bispecific Antibodies

Q: Can nanobodies or bispecific antibodies be used to study BGLU29? A: Yes, nanobodies offer advantages in stability and tissue penetration, making them suitable for targeting conserved epitopes on BGLU29. Bispecific antibodies can be engineered to bind both BGLU29 and another protein of interest, facilitating studies on protein interactions or therapeutic applications.

Data Interpretation and Statistical Analysis

Q: How should I statistically analyze data from experiments using BGLU29 antibodies? A: Use appropriate statistical tests based on the experimental design. For example, ANOVA for comparing multiple groups or t-tests for pairwise comparisons. Consider using non-parametric tests if data do not meet normality assumptions. Also, ensure proper controls are included to account for background or non-specific binding.

Advanced Research Questions: Structural Biology

Q: How can structural biology techniques be applied to study the BGLU29 antibody complex? A: Techniques like X-ray crystallography or cryo-electron microscopy can provide detailed structural information about the BGLU29-antibody complex. This can help understand the molecular basis of recognition and inform further antibody engineering or therapeutic applications.

Methodological Considerations: Cross-Reactivity

Q: How do I assess potential cross-reactivity of BGLU29 antibodies with other proteins? A: Cross-reactivity can be assessed by:

  • Western Blot: Test the antibody against lysates from different cell types or tissues.

  • ELISA: Use a panel of proteins to check for binding.

  • Mass Spectrometry: Identify proteins pulled down by the antibody in a complex mixture.

Advanced Techniques: Single-Cell Analysis

Q: Can single-cell analysis techniques be applied to study BGLU29 using its antibody? A: Yes, techniques like single-cell RNA sequencing combined with antibody-based staining can provide insights into BGLU29 expression at the single-cell level. This can help identify cell subpopulations with unique BGLU29 expression profiles.

Data Integration and Bioinformatics

Q: How can bioinformatics tools be used to integrate data from BGLU29 antibody studies? A: Bioinformatics tools can help analyze large datasets from experiments involving BGLU29 antibodies. For example, using protein structure prediction tools to model the BGLU29-antibody complex or integrating proteomics data to understand protein interactions.

Example Data Table: Epitope Mapping Results

Peptide SequenceAntibody Binding (ELISA OD)
BGLU29_1-100.8
BGLU29_11-200.2
BGLU29_21-301.5

This table illustrates how different peptides of BGLU29 bind to the antibody, helping to identify the epitope.

Example Research Findings: BGLU29 Localization

Using immunofluorescence with BGLU29 antibodies, we found that BGLU29 localizes primarily to the cytoplasm in rice cells, suggesting a role in cellular metabolism.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.